+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 55Years
All Genders
Healthy Volunteers
ID07497555

Effects of Daily Pecan Nut Oil Supplementation on Inflammation and Metabolic Health in Adults with Overweight

Led by Universidad Autonoma de Nuevo Leon · Updated on 2026-03-27

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

This trial investigates whether daily intake of cold-pressed pecan nut oil can reduce inflammation and improve metabolic health in adults with overweight. Researchers study key inflammatory markers like C-reactive protein, interleukin-6, and tumor necrosis factor-alpha, along with blood glucose and lipid profiles. The goal is to understand the impact of pecan nut oil supplementation on these health indicators compared to no intervention. Participants in the experimental group will take 30 mL of pecan nut oil daily for 8 weeks while maintaining their usual diet and physical activity. A control group will continue their normal lifestyle without supplementation. The study involves two evaluation visits at the start and end of the 60-day period, during which blood samples and body measurements will be collected. During the trial, participants will provide dietary information through 24-hour recalls and undergo assessments of inflammation, body weight, body fat, waist and hip circumference, and blood markers. Researchers will monitor changes in inflammatory biomarkers and metabolic parameters from baseline to day 60. The study lasts for about two months with careful monitoring of participants health and adherence to the supplementation protocol.

CONDITIONS

Brief Title

Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Randomized Controlled Parallel-Group Clinical Trial

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here